Abstract
Background: Mobile health technologies show promise in addressing metabolic syndrome, but their comparative effectiveness in large-scale public health interventions remains unclear.
Objective: This study aims to compare the effectiveness of wearable devices (wearable activity trackers) and mobile app–based activity trackers (built-in step counters) in promoting walking practice, improving health behaviors, and reducing metabolic syndrome risk within a national mobile health care program operated by the Korea Health Promotion Institute.
Methods: This retrospective cohort study analyzed data from 46,579 participants in South Korea’s national mobile health care program (2020‐2022). Participants used wearable devices for 12 weeks, after which some switched to built-in step counters. The study collected data on demographics, health behaviors, and metabolic syndrome risk factors at baseline, 12 weeks, and 24 weeks. Outcomes included changes in walking practice, health behaviors, and metabolic syndrome risk factors. Metabolic syndrome risk was assessed based on 5 factors: blood pressure, fasting glucose, waist circumference, triglycerides, and high-density lipoprotein cholesterol. Health behaviors included low-sodium diet preference, nutrition label reading, regular breakfast consumption, aerobic physical activity, and regular walking. To address potential selection bias, propensity score matching was performed, balancing the 2 groups on baseline characteristics including age, gender, education level, occupation, insurance type, smoking status, and alcohol consumption.
Results: Both wearable activity tracker and built-in step counter groups exhibited significant improvements across all evaluated outcomes. The improvement rates for regular walking practice, health behavior changes, and metabolic syndrome risk reduction were high in both groups, with percentages ranging from 45.2% to 60.8%. After propensity score matching, both device types showed substantial improvements across all indicators. The built-in step counter group demonstrated greater reductions in metabolic syndrome risk compared to the wearable device group (odds ratio [OR] 1.20, 95% CI 1.05‐1.36). No significant differences were found in overall health behavior improvements (OR 0.95, 95% CI 0.83‐1.09) or walking practice (OR 0.84, 95% CI 0.70‐1.01) between the 2 groups. Age-specific subgroup analyses revealed that the association between built-in step counters and metabolic syndrome risk reduction was more pronounced in young adults aged 19‐39 years (OR 1.35, 95% CI 1.09‐1.68). Among Android use subgroups, built-in step counters were associated with a higher reduction in health risk factors (OR 1.20, 95% CI 1.03‐1.39).
Conclusions: Both wearable devices and built-in step counters effectively reduced metabolic syndrome risk in a large-scale public health intervention, with built-in step counters showing a slight advantage. The findings suggest that personalized device recommendations based on individual characteristics, such as age and specific health risk factors, may enhance the effectiveness of mobile health interventions. Future research should explore the mechanisms behind these differences and their long-term impacts on health outcomes.
doi:10.2196/64527
Keywords
Introduction
Metabolic syndrome, a cluster of interconnected factors, significantly increases the risk of cardiovascular disease, stroke, and type 2 diabetes, presenting a major challenge to global public health systems [-]. Its rising prevalence imposes substantial economic burdens on health care systems and society []. In response, digital health technologies, particularly mobile apps and wearable devices, have emerged as promising tools for health promotion and disease prevention. These technologies offer advantages such as real-time data collection, personalized feedback, and continuous monitoring, potentially enhancing user engagement and promoting sustainable behavior change to reduce metabolic syndrome risks [,].
Recent studies have demonstrated the potential of mobile health apps in supporting behavior change for diabetes prevention and control. A prospective cohort study in Singapore revealed that higher engagement with a mobile health app led to greater weight loss and HbA1c reduction among adults with overweight or obesity and who had type 2 diabetes or prediabetes []. Similarly, a qualitative research highlighted the importance of integrating app use into routine care and developing guidelines for health care professionals to maximize the benefits of these technologies []. These findings underscore the growing importance of digital interventions in chronic disease management.
However, the efficacy of these digital interventions in public health settings remains a subject of debate. While some studies have reported significant benefits in health promotion and metabolic syndrome management [,], others have found limited or no effects [,]. This discrepancy underscores the need for further research to elucidate the factors that influence the effectiveness of digital health interventions in real-world settings.
Wearable devices are hypothesized to be more effective in promoting health behaviors due to their ability to provide continuous monitoring and immediate feedback, potentially enhancing user engagement and adherence to exercise regimens than mobile apps alone [,,]. However, evidence supporting this hypothesis in large-scale public health interventions remains limited and inconsistent. Some studies suggest that wearables enhance physical activity and health monitoring more effectively than mobile apps due to their continuous tracking and user engagement features []. Conversely, other research indicates minimal differences in health outcomes between users of wearables and mobile apps, suggesting that the technology’s effectiveness may heavily rely on individual user engagement and integration into comprehensive health management strategies [,].
In South Korea, a nationwide mobile health care program operated by the Korea Health Promotion Institute (KHPI) has been operational since 2018, providing an unprecedented opportunity to evaluate the effectiveness of digital health interventions at a population level. This program, implemented through over 220 health centers, offers free wearable activity trackers to eligible participants to mitigate metabolic syndrome risks. Interestingly, some participants have opted to switch to using mobile phone built-in step counters due to personal preference or device loss, creating a natural experiment to compare the efficacy of these 2 approaches.
This study aims to comprehensively evaluate the comparative effectiveness of wearable devices (wearable activity trackers) versus mobile app–based activity trackers (built-in step counters) within this public health service framework. Specifically, we seek to examine their differential impacts on three key outcomes: (1) the promotion of regular walking practices, (2) improvements in overall health behaviors, and (3) the reduction of metabolic syndrome risk factors. By leveraging a large-scale, real-world dataset, we aim to provide nuanced insights into how these technologies influence various aspects of health behavior and outcomes.
Methods
Data Source
The data source is the KHPI’s health center mobile health care program data (2020‐2022). This nationwide program uses Information and Communication Technology to improve preventive health care and self-health capabilities of local residents aged 19 years and older with at least one metabolic syndrome risk factor. The program targets individuals who are generally healthy or without diagnosed chronic diseases. Participants undergo comprehensive health assessments at baseline, 3 months, and 6 months, supported by continuous mobile health care interventions throughout the 6-month program duration.
On enrollment, participants receive a mobile app and an activity tracker (wristband or smartwatch) that monitors biometric data, syncing with the app. The app features automated exercise and dietary logging, delivers personalized health information, and sends exercise and food diaries to participants. From week 12, participants could opt to use their smartphone’s built-in step counter instead of the provided tracker, integrating with fitness tracker apps.
Study Design and Participants
Participants receive medical check-ups, lifestyle assessments, and expert counseling at the beginning, week 12, and week 24. Exclusion criteria included: (1) nonparticipation for over 2 weeks, (2) onset of chronic diseases during the study, (3) incomplete final health questionnaire or pedometer loss by week 27, and (4) moving out of the service area. The Ministry of Health and Welfare oversees the program, with management by the KHPI (
Figure 1) [].
This retrospective cohort study examined changes in walking routines, health behavior patterns, and metabolic syndrome risk factors among participants who either continued using a wearable activity tracker or switched to a smartphone’s built-in step counter after 12 weeks of the program.
The study group comprised individuals with at least 1 metabolic syndrome risk factor who switched from a wearable activity tracker to their smartphone’s built-in step counter after 12 weeks. The control group consisted of individuals with at least 1 metabolic syndrome risk factor who continued using a wearable activity tracker throughout the 24-week intervention period.
Outcome Measures
The practice of “regular walking” was defined based on a survey as engaging in walking for at least 10 minutes consecutively for 5 or more days in the past week. If individuals who did not practice “regular walking” before participating in the program started practicing it afterward, it was considered an improvement in “regular walking.”
Health behaviors were assessed through a comprehensive survey that evaluated 5 key indicators: preference for low-salt diets, regular breakfast consumption, attentiveness to nutritional labels, engagement in regular walking, and participation in aerobic exercises. If any of these 5 health behaviors were not practiced before the program but were adopted afterward, it was considered an improvement in health behaviors.
Metabolic syndrome risk factors were composed of the following five criteria, adopting the diagnostic criteria used domestically based on the National Cholesterol Education Program Adult Treatment Panel III guidelines: (1) elevated blood pressure (systolic blood pressure equal to or above 130 mm Hg or diastolic blood pressure equal to or above 85 mm Hg); (2) elevated fasting blood glucose equal to or above 100 mg/dL; (3) abdominal obesity: male waist circumference equal to or above 90 cm, female waist circumference equal to or above 85 cm; (4) elevated triglycerides equal to or above 150 mg/dL; and (5) decreased high-density lipoprotein cholesterol: male less than 40 mg/dL, female less than 50 mg/dL. If 1 or more of these 5 metabolic syndrome risk factors decreased after participation in the program compared to before, it was considered a reduction in metabolic syndrome risk [].
Potential Confounding Variables
The following potential confounding variables were included as covariates: gender, age group (in 10 y increments), BMI, education level (4 levels), occupation, family type, insurance type (as a proxy for economic status), smoking, alcohol consumption, and mobile operating system.
Statistical Analysis
Baseline demographic characteristics were compared between the built-in step counter users and wearable activity tracker users using chi-square tests. To enhance comparability between the study group and the control group, we performed propensity score matching as our primary analysis method []. Propensity scores were estimated using multivariable logistic regression for all variables mentioned earlier. Matching was performed using a 1:4 nearest neighbor method with the estimated propensity score, and the caliper was strictly set at 0.05. The standardized mean difference was used to compare baseline characteristics of the study group and control group, with imbalance defined as an absolute value greater than 0.1.
Using the propensity score-matched data, we assessed the associations between device type and (1) regular walking practice, (2) health behavior improvement, and (3) metabolic syndrome risk reduction. Odds ratios (OR) with 95% CIs were calculated to quantify these associations.
As a secondary analysis, we conducted multivariable logistic regression with backward elimination, adjusting for potential confounding variables, to further validate our findings. This analysis was performed on the full dataset before propensity score matching.
Subgroup analyses were performed based on age groups (10-30 years: young adults; 40-50 years: middle-aged adults; and 60 years and older: older people) and mobile operating systems (Android and iOS) using both the propensity score-matched data and the full dataset with multivariable logistic regression.
Ethical Considerations
This study was approved by the Bioethics Committee of the CHA University Institutional Review Board (approval E1705/001-003). This study used secondary data from the Public Health Center Mobile Health Care Project, a public health initiative in South Korea. The institutional review board deemed this study exempt from the requirement for additional informed consent, as it involved the secondary analysis of deidentified data from an existing public health program. All data were anonymized and deidentified by the public health centers before being provided for research purposes, with all personal identifiers removed to ensure participant privacy and confidentiality. The data management and analysis procedures strictly adhered to the Personal Information Protection Act of South Korea and institutional data security protocols. As this was a secondary analysis of data from a public health program, participants were not provided additional compensation for this specific research study. Their original participation in the Mobile Health Care Project was voluntary and part of a public health service initiative, without monetary compensation.
Results
Compared to continuous wearable users (n=45,273, 97.2%), the proportion of users who switched to built-in step counters was small (n=1306, 2.8%). The built-in step counter group had a higher proportion of younger adults (19‐39 y), iOS users, and those with higher education levels. This group also included more managers, professionals, and office workers. In contrast, housewives were more likely to continue using wearable devices. Men showed a slightly higher proportion of built-in step counter use compared to women (n=486, 3.2% vs n=820, 2.6%). Among those with a Bachelor’s degree or higher, built-in step counter use was slightly more common than wearable activity tracker use (n=1037, 79.4% vs n=33,659, 74.3%; 
Table 1).
| Variable and class | Wearable activity tracker (n=45,273, 97.2%) | Built-in step counter (n=1306, 2.8%) | Overall | P value | |
| Sex, n (%) | <.001 | ||||
| Male | 14,800 (32.7) | 486 (37.2) | 15,286 (32.8) | ||
| Female | 30,473 (67.3) | 820 (62.8) | 31,293 (67.2) | ||
| Age group (years), n (%) | <.001 | ||||
| 10-19 | 79 (0.2) | 3 (0.2) | 82 (0.2) | ||
| 20-29 | 3034 (6.7) | 163 (12.5) | 3197 (6.9) | ||
| 30-39 | 9652 (21.3) | 357 (27.3) | 10,009 (21.5) | ||
| 40-49 | 16,850 (37.2) | 426 (32.6) | 17,276 (37.1) | ||
| 50-59 | 12,509 (27.6) | 280 (21.4) | 12,789 (27.5) | ||
| 60-69 | 2937 (6.5) | 70 (5.4) | 3007 (6.5) | ||
| 70-79 | 206 (0.5) | 7 (0.5) | 213 (0.5) | ||
| 80-89 | 6 (0) | 0 (0) | 6 (0) | ||
| mOSa, n (%) | <.001 | ||||
| Android | 40,208 (88.8) | 976 (74.7) | 41,184 (86.7) | ||
| iOS | 5062 (11.2) | 330 (25.3) | 5392 (13.3) | ||
| Family type, n (%) | .030 | ||||
| Single person | 3727 (8.2) | 134 (10.3) | 3861 (8.3) | ||
| 2‐3 members | 20,532 (45.4) | 573 (43.9) | 21,105 (45.3) | ||
| ≥4 members | 21,014 (46.4) | 599 (45.9) | 21,613 (46.4) | ||
| Insurance type, n (%) | .363 | ||||
| Health insurance | 44,652 (98.6) | 1287 (98.6) | 45,939 (98.6) | ||
| Medical aid | 359 (0.8) | 8 (0.6) | 367 (0.8) | ||
| Not enrolled | 262 (0.6) | 11 (0.8) | 273 (0.6) | ||
| Education, n (%) | <.001 | ||||
| No education to middle school graduate | 1037 (2.3) | 19 (1.5) | 1056 (2.3) | ||
| High school graduate | 10,577 (23.4) | 250 (19.1) | 10,827 (23.2) | ||
| Bachelor’s degree | 29,340 (64.8) | 900 (68.9) | 30,240 (64.9) | ||
| Master’s degree or higher | 4319 (9.5) | 137 (10.5) | 4456 (9.6) | ||
| Occupation, n (%) | <.001 | ||||
| Manager, expert | 9301 (20.5) | 319 (24.4) | 9620 (20.7) | ||
| Office worker, service worker | 19,542 (43.2) | 579 (44.3) | 20,121 (43.2) | ||
| Sales people, agricultural, forestry, and fishery workers, technician, machine operator, elementary occupation, military personnel | 5374 (11.9) | 140 (10.7) | 5514 (11.8) | ||
| Student | 661 (1.5) | 25 (1.9) | 686 (1.5) | ||
| Homemaker | 8944 (19.8) | 193 (14.8) | 9137 (19.6) | ||
| Unemployed | 1451 (3.2) | 50 (3.8) | 1501 (3.2) | ||
| Smoking, n (%) | .005 | ||||
| No smoking | 36,630 (80.9) | 1031 (78.9) | 37,661 (80.9) | ||
| Used to smoke but currently do not smoke | 5037 (11.1) | 146 (11.2) | 5183 (11.1) | ||
| Smoke occasionally | 815 (1.8) | 37 (2.8) | 852 (1.8) | ||
| Smoke every day | 2791 (6.2) | 92 (7) | 2883 (6.2) | ||
| Alcohol intake, n (%) | .61 | ||||
| <0‐1 times/month | 20,632 (45.6) | 558 (42.7) | 21,190 (45.5) | ||
| 2‐4 times/month | 16,768 (37) | 486 (37.2) | 17,254 (37) | ||
| 2‐3 times/week | 6304 (13.9) | 211 (16.2) | 6515 (14) | ||
| ≥4 times/week | 1569 (3.5) | 51 (3.9) | 1620 (3.5) | ||
| General or intensive management neededc, n (%) | .98 | ||||
| General | 29,584 (65.4) | 853 (65.3) | 30,437 (65.3) | ||
| Intensive | 15,689 (34.7) | 453 (34.7) | 16,142 (34.7) | ||
| BMIb (kg/m2), mean (SD) | 25.4 (3.8) | 25.7 (4) | 25.4 (3.8) | .01 | |
| Waist circumference (cm), mean (SD) | |||||
| Male | 92.6 (8.9) | 93.7 (9.8) | 92.6 (9.0) | .02 | |
| Female | 85.2 (9.6) | 84.5 (10.2) | 85.1 (9.6) | .06 | |
| Blood pressure (mm Hg), mean (SD) | |||||
| Systolic | 126.3 (13.5) | 125.4 (13.4) | 126.3 (13.5) | .01 | |
| Diastolic | 80.4 (10.4) | 79.8 (10.5) | 80.4 (10.4) | .06 | |
| FBGd (mg/dL), mean (SD) | 98.0 (13.2) | 97.8 (11.9) | 98.0 (13.1) | .60 | |
| Triglyceride (mg/dL), mean (SD) | 150.0 (84.9) | 150.0 (80.9) | 150.0 (84.8) | .99 | |
| HDLe cholesterol (mg/dL), mean (SD) | 55.7 (14.6) | 54.9 (14.6) | 55.7 (14.6) | .07 | |
amOS: mobile operating system.
bBMI: body mass index
cIndividuals exhibiting 1-2 metabolic syndrome risk factors were allocated to a standard management group, whereas those presenting with 3-5 risk factors were assigned to an intensive management group.
dFBG: fasting blood glucose.
eHDL: high-density lipoprotein.
Overall, 54% (n=25,158) of participants showed a reduction in metabolic syndrome risk, with women demonstrating a higher rate than men (n=17,371, 55.5% vs n=7787, 50.9%). The reduced risk group had slightly higher proportions of young adults (10‐39 years), built-in step counter users, and iOS users. Participants with healthier baseline lifestyle indicators (nonsmoking, lower alcohol consumption, and lower BMI) were more prevalent in the reduced-risk group. The proportion of individuals showing a reduction in metabolic syndrome risk was slightly higher among those who practiced fewer health behaviors at baseline (Table 2).
| Characteristic | No metabolic syndrome risk reduction (n=21,421, 46%), n (%) | Metabolic syndrome risk reduction (n=25,158, 54%), n (%) | Overall (n=46,579, 100%), n (%) | P value | |
| Sex | <.001 | ||||
| Male | 7499 (35) | 7787 (31) | 15,286 (32.8) | ||
| Female | 13,922 (46) | 17,371 (69.1) | 31,293 (67.2) | ||
| Age (years) | <.001 | ||||
| 10‐29 | 1334 (6.2) | 1945 (7.7) | 3279 (7) | ||
| 30-39 | 4612 (21.5) | 5397 (21.5) | 10,009 (21.5) | ||
| 40-49 | 7979 (37.3) | 9297 (37) | 17,276 (37.1) | ||
| 50-59 | 5912 (27.6) | 6877 (27.3) | 12,789 (27.5) | ||
| 60-69 | 1470 (6.9) | 1537 (6.1) | 3007 (6.5) | ||
| 70‐89 | 114 (0.5) | 105 (0.4) | 219 (0.5) | ||
| Family type | .47 | ||||
| Single person | 1749 (8.2) | 2112 (8.4) | 3861 (8.3) | ||
| 2‐3 members | 9762 (45.6) | 11,343 (45.1) | 21,105 (45.3) | ||
| ≥4 members | 9910 (46.3) | 11,703 (46.5) | 21,613 (46.4) | ||
| Education | .03 | ||||
| No education to middle school graduate | 508 (2.4) | 548 (2.2) | 1056 (2.3) | ||
| High school graduate | 5062 (23.6) | 5765 (22.9) | 10,827 (23.2) | ||
| Bachelor’s degree | 13,762 (64.3) | 16,478 (54.5) | 30,240 (64.9) | ||
| Master’s degree or higher | 2089 (9.8) | 2367 (9.4) | 4456 (9.6) | ||
| Insurance | .79 | ||||
| Health insurance | 21,125 (98.6) | 24,814 (98.6) | 45,939 (98.6) | ||
| Medical aid | 174 (0.8) | 193 (0.8) | 367 (0.8) | ||
| Not enrolled | 122 (0.6) | 151 (0.6) | 273 (0.6) | ||
| Device type | .007 | ||||
| Wearable | 20,868 (97.4) | 24,405 (97) | 45,273 (97.2) | ||
| Switched to app | 553 (2.6) | 753 (3) | 1306 (2.8) | ||
| mOSa | <.001 | ||||
| Android | 19,097 (89.2) | 22,087 (87.8) | 41,184 (88.4) | ||
| iOS | 2323 (10.9) | 3069 (12.2) | 5392 (11.6) | ||
| Smoking | <.001 | ||||
| No smoking | 17,020 (79.5) | 20,641 (82.1) | 37,661 (80.9) | ||
| Used to smoke but currently do not smoke | 2516 (11.8) | 2667 (10.6) | 5183 (11.1) | ||
| Smoke occasionally | 426 (2) | 426 (1.7) | 852 (1.8) | ||
| Smoke every day | 1459 (6.8) | 1424 (5.7) | 2883 (6.2) | ||
| Alcohol intake | .001 | ||||
| <0‐1 times/month | 9597 (44.8) | 11,593 (46.1) | 21,190 (45.5) | ||
| 2‐4 times/month | 7970 (37.2) | 9284 (36.9) | 17,254 (37) | ||
| 2‐3 times/week | 3073 (14.4) | 3442 (13.7) | 6515 (14) | ||
| ≥4 times/week | 781 (3.7) | 839 (3.3) | 1620 (3.5) | ||
| BMI | <.001 | ||||
| <18.5 | 221 (1) | 381 (1.5) | 602 (1.3) | ||
| 18.5‐23 | 4597 (21.5) | 6657 (26.5) | 11,254 (24.2) | ||
| 23‐25 | 4346 (20.3) | 5887 (23.4) | 10,233 (22) | ||
| 25‐30 | 9176 (42.8) | 9849 (39.2) | 19,025 (40.9) | ||
| 30‐35 | 2551 (11.9) | 1998 (7.9) | 4549 (9.8) | ||
| ≥35 | 530 (2.5) | 385 (1.5) | 915 (2) | ||
| Number of metabolic syndrome risk factors at baseline | <.001 | ||||
| 1 | 9439 (44.1) | 6784 (27) | 16,223 (34.8) | ||
| 2 | 6705 (31.3) | 7509 (29.9) | 14,214 (30.5) | ||
| 3 | 3641 (17) | 6176 (24.6) | 9817 (21.1) | ||
| 4 | 1420 (6.6) | 3602 (14.3) | 5022 (10.8) | ||
| 5 | 216 (1) | 1087 (4.3) | 1303 (2.8) | ||
| Hypertension risk | <.001 | ||||
| Yes | 10,157 (47.4) | 14,846 (59) | 25,003 (53.7) | ||
| No | 11,264 (52.6) | 10,312 (41) | 21,576 (46.3) | ||
| Diabetes mellitus risk | <.001 | ||||
| Yes | 7079 (33.1) | 11,379 (45.2) | 18,458 (39.6) | ||
| No | 14,342 (67) | 13,779 (54.8) | 28,121 (60.4) | ||
| High waist circumference | .16 | ||||
| Yes | 12,298 (57.4) | 14,607 (58.1) | 26,905 (57.8) | ||
| No | 9123 (42.6) | 10,551 (42) | 19,674 (42.2) | ||
| High TGb | <.001 | ||||
| Yes | 6703 (31.3) | 11,806 (46.9) | 18,509 (39.7) | ||
| No | 14,718 (68.7) | 13,352 (53.1) | 28,070 (60.3) | ||
| Low HDLc cholesterol | |||||
| Yes | 4295 (20.1) | 7535 (30) | 11,830 (25.4) | ||
| No | 17,126 (80) | 17,623 (70.1) | 34,749 (74.6) | ||
| Number of health behaviors being practicing at baseline | <.001 | ||||
| 0 | 221 (1) | 381 (1.5) | 602 (1.3) | ||
| 1 | 4597 (21.5) | 6657 (26.5) | 11,254 (24.2) | ||
| 2 | 4346 (20.3) | 5887 (23.4) | 10,233 (22) | ||
| 3 | 9176 (42.8) | 9849 (39.2) | 19,025 (40.9) | ||
| 4 | 2551 (11.9) | 1998 (7.9) | 4549 (9.8) | ||
| 5 | 530 (2.5) | 385 (1.5) | 915 (2) | ||
amOS: mobile operation system.
bTG: triglyceride.
cHDL: high density lipoprotein.
After ensuring comparability between the wearable activity tracker and built-in step counter groups through propensity score matching, an analysis was conducted. Before matching, there were differences in various variables such as age, insurance type, and education level. However, after matching, the absolute values of the standardized mean differences were all below 0.1, indicating no significant differences between the 2 groups ().
Table 3 presents the results of the propensity score-matched analysis. For regular walking practice, there was no significant difference between the 2 groups (OR 0.84, 95% CI 0.70‐1.01). Similarly, no significant differences were found in overall health behavior improvements (OR 0.95, 95% CI 0.83‐1.09).
Notably, the built-in step counter group demonstrated greater reductions in metabolic syndrome risk compared to the wearable device group (OR 1.20, 95% CI 1.05‐1.36). This significant association was particularly pronounced among young adults aged 10‐30 years (OR 1.35, 95% CI 1.09‐1.68). The effect was less pronounced and not statistically significant for the 40‐50 years age group (OR 1.15, 95% CI 0.97‐1.38) and the 60‐80 years age group (OR 1.08, 95% CI 0.61‐1.94).
When analyzed by the mobile operating system, Android users showed a significant association between built-in step counter use and metabolic syndrome risk reduction (OR 1.20, 95% CI 1.03‐1.39). For iOS users, the association was in the same direction but not statistically significant (OR 1.14, 95% CI 0.88‐1.50), possibly due to the smaller sample size in this subgroup (Table 3).
| Study population and number of participants by device type | Propensity score matched model ORa (95% CI) | ||||
| Not practicing regular walking at baselineb | |||||
| Wearable activity tracker (n=2468, 79.9%) | reference | ||||
| Built-in step counter (n=621, 20.1%) | 0.84 (0.70‐1.01) | ||||
| Not practicing any health behaviors at baselinec | |||||
| Wearable activity tracker (n=4951, 80%) | reference | ||||
| Built-in step counter (n=1244, 20%) | 0.95 (0.83‐1.09) | ||||
| One or more metabolic syndrome risk factors at baselined | |||||
| Overall | |||||
| Wearable activity tracker (n=5195, 80%) | reference | ||||
| Built-in step counter (n=1308, 20%) | 1.20 (1.05‐1.36) | ||||
| 10‐39 years | |||||
| Wearable activity tracker (n=2035, 83%) | reference | ||||
| Built-in step counter (n=516, 17%) | 1.35 (1.09‐1.68) | ||||
| 40‐59 years | |||||
| Wearable activity tracker (n=2808, 80%) | reference | ||||
| Built-in step counter (n=704, 20%) | 1.15 (0.97‐1.38) | ||||
| 60‐89 years | |||||
| Wearable activity tracker (n=288, 79.9%) | reference | ||||
| Built-in step counter (n=75, 20.1%) | 1.08 (0.61‐1.94) | ||||
| Android | |||||
| Wearable activity tracker (n=3893, 80%) | reference | ||||
| Built-in step counter (n=975, 20%) | 1.20 (1.03‐1.39) | ||||
| iOS | |||||
| Wearable (n=1250, 79.3%) | reference | ||||
| Built-in step counter (n=326, 21.7%) | 1.14 (0.88‐1.50) | ||||
aOR: odds ratio.
bOutcome: practicing walking.
cOutcome: improved in 1 or more health behaviors.
dOutcome: reduced in 1 or more metabolic syndrome risk factors.
Across all outcomes—regular walking practice, health behavior improvements, and metabolic syndrome risk reduction—both wearable activity tracker and built-in step counter groups showed high improvement rates, ranging from 45.2% to 60.8% (Table 4).
| Study population and number of participants by device type | Improved, n (%) | Crude model, ORa (95% CI) | Covariates model Ib, OR (95% CI) | Covariates model IIc, OR (95% CI) | |||
| Not practicing regular walking at baselined | |||||||
| Wearable activity tracker (n=22,795, 97.3%) | 11,705 (51.3) | reference | reference | reference | |||
| Built-in step counter (n=624, 2.7%) | 282 (45.2) | 0.78 (0.67‐0.92) | 0.82 (0.70‐0.96) | 0.83 (0.66‐1.06) | |||
| Not practicing any health behaviors at baselinee | |||||||
| Wearable activity tracker (n=43,666, 96.5%) | 26,569 (60.8) | reference | reference | reference | |||
| Built-in step activity tracker (n=1253, 2.8%) | 730 (58.3) | 0.89 (0.80‐1.00) | 0.92 (0.82‐1.03) | 0.94 (0.84‐1.04) | |||
| One or more metabolic syndrome risk factors at baselinef | |||||||
| Wearable activity tracker (n=45,273, 97.2%) | 24,405 (53.9) | reference | reference | reference | |||
| Built-in step counter (n=1306, 2.8%) | 753 (57.7) | 1.16 (1.04‐1.30) | 1.16 (1.04‐1.29) | 1.15 (1.03‐1.30) | |||
aOR: odds ratio.
bCovariates model Ⅰ: adjusted for age, sex.
cCovariates model Ⅱ: adjusted for age, sex, education, family type, insurance type, occupation, BMI, smoking, alcohol intake, mobile operation system type.
dOutcome: regular walking practice.
eOutcome: improved in 1 or more health behaviors.
fOutcome: reduced in 1 or more metabolic syndrome risk factors.
To further validate our findings, we conducted multivariable logistic regression analyses, presented in Table 4. These results were generally consistent with the propensity score-matched analysis. For regular walking practice, wearable activity trackers showed a slight advantage over built-in step counters in the crude model (OR 0.78, 95% CI 0.67‐0.92). However, this association weakened after adjusting for multiple covariates (fully adjusted OR 0.83, 95% CI 0.66‐1.06). No significant association was found between device type and overall health behavior improvement across all models (fully adjusted OR 0.94, 95% CI 0.84‐1.04). Interestingly, the use of built-in step counters was associated with greater reductions in metabolic syndrome risk compared to wearable activity trackers. This relationship remained consistent and statistically significant across all 3 models (crude OR 1.16, 95% CI 1.04‐1.30; fully adjusted OR 1.15, 95% CI 1.03‐1.30; Table 4).
Table 5 presents the results of subgroup analyses using multivariable logistic regression. These analyses revealed nuanced differences across age groups and mobile operating systems. Wearable activity trackers were significantly associated with better improvements in regular walking practice only in the 40-59 year old group (OR 0.80, 95% CI 0.64‐0.99). The device type did not significantly impact health behavior improvement across any age group. For metabolic syndrome risk, built-in step counters were significantly associated with greater risk reduction only among young adults (10-39 years; OR 1.21, 95% CI 1.01‐1.45), aligning with the findings from the propensity score-matched analysis.
In analyses by the mobile operating system, Android users showed a significant association between built-in step counter use and (1) less regular walking practice (OR 0.81, 95% CI 0.67‐0.97), and (2) metabolic syndrome risk reduction (OR 1.13, 95% CI 1.00‐1.29). iOS users demonstrated no significant differences between device types for any outcome, possibly due to limited statistical power.
| Study population, subgroup, and number of participants by device type | Covariates model II, ORa (95% CI) | ||
| Not practicing walking at baselineb | |||
| 10-39 years | |||
| Wearable activity tracker (n=6458, 96.1%) | reference | ||
| Built-in step counter (n=261, 3.9%) | 0.89 (0.69‐1.14) | ||
| 40-59 years | |||
| Wearable activity tracker (n=15,144, 97.8%) | reference | ||
| Built-in step counter (n=337, 2.2%) | 0.80 (0.64‐0.99) | ||
| 60-89 years | |||
| Wearable activity tracker (n=1193, 97.9%) | reference | ||
| Built-in step counter 26 (2.1) | 0.61 (0.27‐1.37) | ||
| Android | |||
| Wearable activity tracker (n=20,287, 97.7%) | reference | ||
| Built-in step counter (n=477, 2.3%) | 0.81 (0.67‐0.97) | ||
| iOS | |||
| Wearable activity tracker (n=2507, 94.5%) | reference | ||
| Built-in step counter (n=147, 5.5%) | 0.89 (0.63‐1.25) | ||
| Not practicing any health behaviors at baselinec | |||
| 10-39 years | |||
| Wearable activity tracker (n=12,270, 96.1%) | reference | ||
| Built-in step counter (n=505, 4%) | 0.86 (0.72‐1.03) | ||
| 40-59 years | |||
| Wearable activity tracker (n=27,856, 97.7%) | reference | ||
| Built-in step counter (n=668, 2.3%) | 1.00 (0.85‐1.17) | ||
| 60-89 years | |||
| Wearable activity tracker (n=2788, 97.5%) | reference | ||
| Built-in step counter (n=73, 2.5%) | 0.72 (0.45‐1.17) | ||
| Android | |||
| Wearable activity tracker (n=38,190, 97.6%) | reference | ||
| Built-in step counter (n=932, 2.4%) | 0.94 (0.83‐1.08) | ||
| iOS | |||
| Wearable activity tracker (n=4811, 93.9%) | reference | ||
| Built-in step counter (n=314, 6.1%) | 0.85 (0.67‐1.07) | ||
| One or more Metabolic syndrome risk factors at baselined | |||
| 10-39 years | |||
| Wearable activity tracker (n=12,765, 96.1%) | reference | ||
| Built-in step counter (n=523, 3.9%) | 1.21 (1.01‐1.45) | ||
| 40-59 years | |||
| Wearable activity tracker (n=29,359, 97.7%) | reference | ||
| Built-in step counter (n=706, 2.4%) | 1.11 (0.96‐1.29) | ||
| 60-89 years | |||
| Wearable activity tracker (n=3149, 97.2%) | reference | ||
| Built-in step counter (n=77, 2.8%) | 1.17 (0.74‐1.86) | ||
| Android | |||
| Wearable activity tracker (n=40,208, 97.6%) | reference | ||
| Built-in step counter (n=976, 2.4%) | 1.13 (1.00‐1.29) | ||
| iOS | |||
| Wearable activity tracker (n=5062, 93.9%) | reference | ||
| Built-in step counter (n=330, 6.1%) | 1.18 (0.94‐1.49) | ||
aOR: odds ratio.
bOutcome: regular walking practice.
cOutcome: improved in 1 or more health behaviors.
dOutcome: reduced in 1 or more metabolic syndrome risk factors.
Discussion
Principal Results
This study compared the effects of continuously using wearable devices versus switching to built-in step counters after 12 weeks on walking practice, health behaviors, and metabolic syndrome risk reduction. Both groups showed substantial improvements across all indicators, with 45%‐61% of participants demonstrating positive changes.
Using propensity score-matched analysis, we found that the group that switched to built-in step counters showed better results in metabolic syndrome risk reduction (OR 1.20, 95% CI 1.05‐1.36). This effect was particularly pronounced among young adults aged 10‐30 years (OR 1.35, 95% CI 1.09‐1.68). There were no significant differences between groups in walking practice (OR 0.84, 95% CI 0.70‐1.01) or overall health behaviors (OR 0.95, 95% CI 0.83‐1.09).
Age-specific subgroup analyses revealed that the effects of device type varied across age groups, with the association between switching to built-in step counters and metabolic syndrome risk reduction being more pronounced in young adults (10-30 years).
Comparison With Previous Studies
Our research findings contribute to the evidence supporting the effectiveness of mobile technology in promoting physical activity and health behaviors. The substantial improvements observed across all indicators in both groups align with previous studies demonstrating the positive impact of smartphone apps and activity trackers on physical activity levels and health outcomes [,-]. Recent research further supports this, showing that higher engagement with mobile health apps led to greater weight loss and HbA1c reduction in adults with overweight or obesity and type 2 diabetes or prediabetes [].
Our analysis showed no significant difference in walking practice between wearable device users and built-in step counter users (OR 0.84, 95% CI 0.70‐1.01). This result contrasts with some previous studies demonstrating greater benefits of wearable devices. A randomized controlled trial (RCT) found that among inactive overweight or obese postmenopausal women, a Fitbit-based intervention significantly increased moderate to vigorous physical activity compared to standard pedometers (Fitbit: +62 min/week vs pedometer: –3 min/week; P=.01) []. Similarly, another RCT reported significantly higher daily average step counts in a group using both app and wearable devices compared to an app-only group (8165 vs 6034 steps; P=.02) []. The differences between our results and those of previous studies may stem from variations in study design, target population, and intervention duration. For instance, while Cadmus-Bertram et al [] focused on a specific population (postmenopausal women) and measured moderate to vigorous physical activity as the primary outcome, this study included a broader population and evaluated walking practice and overall health behaviors.
Regarding health behavior improvements, our propensity score-matched analysis found no significant differences between the 2 groups (OR 0.95, 95% CI 0.83‐1.09). This partially aligns with findings from a previous study, which reported no difference in energy intake changes between mobile app and wearable “Bite Counter” device groups []. However, the same study observed a significant increase in physical activity in the wearable device group (mean 2015.4, SD 684.6 metabolic equivalent (METs) min/week; P=.02), which contrasts with our findings. Recent research found that both synchronous (videoconference) and asynchronous (prerecorded videos) digital interventions demonstrated good acceptability among inactive adults, suggesting various digital tools can effectively promote physical activity []. The importance of integrating app use into routine care has been highlighted, which may explain the similar improvements in both groups in this study []. These findings underscore the complexity of digital health interventions and the need for tailored approaches.
In metabolic syndrome risk reduction, our propensity score-matched analysis revealed significant decreases in both groups, with a slight advantage in the group that switched to built-in step counters (OR 1.20, 95% CI 1.05‐1.36). This contrasts with some previous studies, where mobile phone–based health coaching showed more effectiveness in improving metabolic syndrome–related indicators []. However, our results align with other studies demonstrating the potential of mobile software and wearable devices in reducing metabolic syndrome risk [].
A notable aspect of our findings is the high rate of metabolic syndrome risk reduction (over 50%) in both groups, possibly due to the well-designed intervention characteristics of the national-level public health program. These results are similar to a 12-week RCT where the intervention group receiving physical activity feedback through wearable devices showed significant improvements in key clinical indicators of metabolic syndrome []. This supports the potential effectiveness of well-designed mobile health interventions in reducing metabolic syndrome risk.
However, mixed results are also present in the literature. Some studies report that mobile interventions have no significant impact on physical activity or health outcomes [,]. For instance, a study on overweight Taiwanese adults found that activity promotion systems provided short-term benefits for physical activity but did not significantly affect metabolic abnormalities []. Similarly, an RCT of multidimensional physical activity feedback intervention for primary care patients at risk of chronic diseases showed no effect on physical activity or health outcomes [].
These conflicting results highlight the complexity of using technology for health risk management and physical activity promotion. The effectiveness of such interventions may depend on various factors, including intervention design, user engagement, and individual health status []. Our findings, along with these recent studies, highlight the potential of digital health interventions in chronic disease management. They suggest that the effectiveness of such interventions may not solely depend on the specific technology used (eg, wearable devices vs built-in step counters), but also on how well these technologies are integrated into comprehensive health programs and how they engage users in multiple aspects of health management. Our findings align with recent research on digital health interventions for chronic disease management. The mobile health care program incorporated gamification elements, defined as “the use of game design elements in nongame contexts” []. This was evident in features like national step count rankings and health behavior scores, which were designed to engage users and encourage healthier behaviors. These gamified components, along with performance-based rewards, likely enhanced user engagement and motivation. Our results support the effectiveness of gamification strategies in health interventions, consistent with findings from a systematic review on type 2 diabetes self-management, which reported improvements in key health outcomes, such as glycated hemoglobin levels and BMI []. This underscores the importance of considering these elements when implementing mobile health interventions in public health settings and suggests that while mobile health technologies show promise, their impact may vary across different contexts and populations.
Potential Mechanisms and Explanations
The differential effects observed between wearable devices and built-in step counters in this study can be explained by several potential mechanisms. The marginal advantage of wearable devices in promoting walking activity may stem from their continuous and real-time data collection capabilities. These devices provide immediate feedback, which has been shown to enhance user engagement and motivation []. This instant feedback loop can heighten awareness of physical activity levels and encourage users to be more active throughout the day.
The noninferiority or similar health impact of built-in step counters compared to wearable trackers suggests that simplicity and accessibility play crucial roles in promoting health behaviors. This aligns with findings emphasizing that simple pedometers could be more effective than complex wearable trackers or smartphone apps in public health interventions. A meta-regression analysis of 57 RCTs revealed that body-worn trackers or smartphone apps were less effective than pedometers in interventions lasting less than 4 months (–834 steps/day; 95% CI –1542 to –126]) []. This underscores the potential value of straightforward, easily accessible tools in promoting physical activity within public health initiatives.
In this study, younger individuals, those with higher education, and iOS users showed higher rates of switching to built-in step counters. This may reflect these groups’ higher understanding and adherence, potentially relating to the slightly better health risk factor reduction observed in the built-in step counter group. However, the possibility of selection or residual bias should be considered.
Multivariable logistic regression analysis confirmed an association between built-in step counter use and greater metabolic syndrome risk reduction, though no difference was found in health behaviors between the 2 groups, and the strength of the association was weak. Subgroup analyses revealed differences only in specific groups, limiting result generalizability and suggesting the need for personalized interventions.
Limitations
This study provides valuable insights into the real-world effectiveness of wearable devices and built-in step counters within a national public health program. Using a large-scale nationwide dataset enhances statistical power and generalizability. The application of diverse statistical methodologies, including propensity analysis, strengthens the reliability of the results.
However, several limitations should be noted. As an observational study, it has inherent limitations in establishing causality. The small number of participants who switched to built-in step counters may limit statistical power in some analyses. Reliance on self-reported data and the inability to assess long-term effects are significant limitations. Additionally, the study design, where all participants initially used wearable devices for 12 weeks before some switched to built-in step counters, limits the ability to compare effects from the intervention’s start. This design feature means that the effects of built-in step counters cannot be completely isolated from the potential carryover effects of initial wearable device use. Finally, our analysis may be limited by unmeasured confounding factors not available in our dataset.
Implications and Future Research Directions
Our findings provide important implications for the design and implementation of public mobile health care initiatives. While wearable devices may offer some advantages in promoting physical activity, built-in step counters can be equally effective, particularly in reducing metabolic syndrome risk among young adults.
These results support a more personalized approach to device recommendations in public health programs, aligning with the growing trend toward personalized digital health interventions [,]. Programs could offer options between wearable devices and built-in step counters based on individual preferences, age, and other relevant factors, potentially improving intervention adherence and outcomes.
The high rate of metabolic syndrome risk reduction observed (over 50% in both groups) suggests that well-designed technology-supported public health interventions can significantly impact population health, especially when integrated into comprehensive national health programs.
Future research should explore the mechanisms behind age-related differences in device effectiveness. Longitudinal studies with longer follow-up periods could provide insights into the long-term effects of various device types on health outcomes, addressing gaps identified in previous research [].
Conclusions
This study compared the effectiveness of wearable devices and built-in step counters in a large-scale national mobile health care program. Both device types were effective in reducing metabolic syndrome risk, with the group switching to built-in step counters showing slightly better results (OR 1.20, 95% CI 1.05‐1.36). Wearable devices showed a marginal advantage in promoting walking practice, but there was no significant difference in overall health behavior improvement.
These findings suggest the importance of providing device selection options based on individual characteristics and preferences in public mobile health care programs. The high rate of metabolic syndrome risk reduction observed in both groups (over 50%) demonstrates the potential of well-designed mobile health interventions.
Acknowledgments
This study was supported by a grant (20230813B0AA-00) from the Korea Health Promotion Institute. This work was supported by the National Research Foundation of Korea grant funded by the Korea government (MSIT; 2022R1F1A1063404).
Conflicts of Interest
None declared.
Multimedia Appendix 1
Standard mean differences before and after propensity score matching.
DOCX File, 24 KBReferences
- Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113-1132. [CrossRef] [Medline]
- Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403-414. [CrossRef] [Medline]
- Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645. [CrossRef] [Medline]
- Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev. Dec 2008;29(7):777-822. [CrossRef] [Medline]
- Huckvale K, Prieto JT, Tilney M, Benghozi PJ, Car J. Unaddressed privacy risks in accredited health and wellness apps: a cross-sectional systematic assessment. BMC Med. 2015;13:214. [CrossRef] [Medline]
- Kim HJ, Lee KH, Lee JH, Youk H, Lee HY. The effect of a mobile and wearable device intervention on increased physical activity to prevent metabolic syndrome: observational study. JMIR Mhealth Uhealth. Feb 24, 2022;10(2):e34059. [CrossRef] [Medline]
- Lim SL, Tay MHJ, Ong KW, et al. Association between mobile health app engagement and weight loss and glycemic control in adults with type 2 diabetes and prediabetes (D’LITE Study): prospective cohort study. JMIR Diabetes. 2022;7(3):e35039. [CrossRef] [Medline]
- Bults M, van Leersum CM, Olthuis TJJ, Bekhuis REM, den Ouden MEM. Mobile health apps for the control and self-management of type 2 diabetes mellitus: qualitative study on users’ acceptability and acceptance. JMIR Diabetes. 2023;8:e41076. [CrossRef] [Medline]
- Keshet A, Reicher L, Bar N, Segal E. Wearable and digital devices to monitor and treat metabolic diseases. Nat Metab. 2023;5(4):563-571. [CrossRef] [Medline]
- Natalucci V, Marmondi F, Biraghi M, Bonato M. The effectiveness of wearable devices in non-communicable diseases to manage physical activity and nutrition: where we are? Nutrients. 2023;15(4):913. [CrossRef] [Medline]
- Shi C. Mobile phone messaging for facilitating self-management of long-term illnesses: summaries of nursing care-related systematic reviews from the Cochrane library. JBI Evidence Implementation. Dec 2013;11(4):344-345. [CrossRef]
- Vorrink SNW, Kort HSM, Troosters T, Zanen P, Lammers JWJ. Efficacy of an mHealth intervention to stimulate physical activity in COPD patients after pulmonary rehabilitation. Eur Respir J. 2016;48(4):1019-1029. [CrossRef] [Medline]
- Piwek L, Ellis DA, Andrews S, Joinson A. The rise of consumer health wearables: promises and barriers. PLoS Med. 2016;13(2):e1001953. [CrossRef] [Medline]
- Lee SK, Kim MG, Oh Y, et al. Effects of walking promotion using smart mobile activity meter on changes in metabolic health. Phys Act Health. 2023;7(1):153-165. [CrossRef]
- Patel MS, Asch DA, Volpp KG. Wearable devices as facilitators, not drivers, of health behavior change. JAMA. 2015;313(5):459-460. [CrossRef] [Medline]
- Patel S, Park H, Bonato P, Chan L, Rodgers M. A review of wearable sensors and systems with application in rehabilitation. J Neuroeng Rehabil. 2012;9:21. [CrossRef] [Medline]
- Oba T, Takano K, Katahira K, Kimura K. Use patterns of smartphone apps and wearable devices supporting physical activity and exercise: large-scale cross-sectional survey. JMIR Mhealth Uhealth. 2023;11:e49148. [CrossRef] [Medline]
- Ministry of health and welfare. Korea health promotion development institute. guide to community integrated health promotion projects: physical activity. 2023. URL: https://www.khepi.or.kr/kps/publish/view?menuId=MENU00890&page_no=B2017003&pageNum=2&siteId=&srch_text=2023&srch_cate=28&srch_type=ALL&str_clft_cd_list=&str_clft_cd_type_list=&board_idx=10913 [Accessed 2025-02-10]
- Eckel RH, Cornier MA. Update on the NCEP ATP-III emerging cardiometabolic risk factors. BMC Med. 2014;12:115. [CrossRef] [Medline]
- Caliendo M, Kopeinig S. Some practical guidance for the implementation of propensity score matching. J Econ Surv. 2008;22(1):31-72. [CrossRef]
- Brickwood KJ, Watson G, O’Brien J, Williams AD. Consumer-based wearable activity trackers increase physical activity participation: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2019;7(4):e11819. [CrossRef] [Medline]
- Jang M, Park JH, Kim GM, et al. Health provider’s feedback on physical activity surveillance using wearable device-smartphone application for adults with metabolic syndrome; a 12-week randomized control study. Diabetes Metab Syndr Obes. 2023;16:1357-1366. [CrossRef] [Medline]
- Rosa I, Lages M, Grilo C, Barros R, Guarino MP. mHealth applications to monitor lifestyle behaviors and circadian rhythm in clinical settings: current perspective and future directions. Front Public Health. 2022;10:862065. [CrossRef] [Medline]
- Dehghan Ghahfarokhi A, Vosadi E, Barzegar H, Saatchian V. The effect of wearable and smartphone applications on physical activity, quality of life, and cardiovascular health outcomes in overweight/obese adults: a systematic review and meta-analysis of randomized controlled trials. Biol Res Nurs. 2022;24(4):503-518. [CrossRef] [Medline]
- Cadmus-Bertram LA, Marcus BH, Patterson RE, Parker BA, Morey BL. Randomized trial of a Fitbit-based physical activity intervention for women. Am J Prev Med. Sep 2015;49(3):414-418. [CrossRef] [Medline]
- Kim JW, Ryu B, Cho S, et al. Impact of personal health records and wearables on health outcomes and patient response: three-arm randomized controlled trial. JMIR Mhealth Uhealth. 2019;7(1):e12070. [CrossRef] [Medline]
- Turner-McGrievy GM, Wilcox S, Boutté A, et al. The dietary intervention to enhance tracking with mobile devices (diet mobile) study: a 6-month randomized weight loss trial. Obesity (Silver Spring). Aug 2017;25(8):1336-1342. [CrossRef] [Medline]
- Dawson JK, Ede A, Phan M, Sequeira A, Teng HL, Donlin A. Feasibility and acceptability of a mobile health exercise intervention for inactive adults: 3-arm randomized controlled pilot trial. JMIR Form Res. 2024;8:e52428. [CrossRef] [Medline]
- Wayne N, Perez DF, Kaplan DM, Ritvo P. Health coaching reduces HBA1C in type 2 diabetic patients from a lower-socioeconomic status community: a randomized controlled trial. J Med Internet Res. Oct 5, 2015;17(10):e224. [CrossRef] [Medline]
- Arora S, Peters AL, Burner E, Lam CN, Menchine M. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med. Jun 2014;63(6):745-754. [CrossRef] [Medline]
- Yang YP, Wang CJ, Wang JJ, et al. The effects of an activity promotion system on active living in overweight subjects with metabolic abnormalities. Obes Res Clin Pract. 2017;11(6):718-727. [CrossRef] [Medline]
- Peacock OJ, Western MJ, Batterham AM, et al. Effect of novel technology-enabled multidimensional physical activity feedback in primary care patients at risk of chronic disease—the MIPACT study: a randomised controlled trial. Int J Behav Nutr Phys Act. Aug 8, 2020;17(1):99. [CrossRef] [Medline]
- Deterding S, Dixon D, Khaled R, Nacke L. From game design elements to gamefulness: defining gamification. Presented at: The 15th International Academic MindTrek Conference: Envisioning Future Media Environments; Sep 28-30, 2011; Tampere, Finland. [CrossRef]
- Ossenbrink L, Haase T, Timpel P, et al. Effectiveness of digital health interventions containing game components for the self-management of type 2 diabetes: systematic review. JMIR Serious Games. Jun 1, 2023;11:e44132. [CrossRef] [Medline]
- Chaudhry UAR, Wahlich C, Fortescue R, Cook DG, Knightly R, Harris T. The effects of step-count monitoring interventions on physical activity: systematic review and meta-analysis of community-based randomised controlled trials in adults. Int J Behav Nutr Phys Act. Oct 9, 2020;17(1):129. [CrossRef] [Medline]
- Schroé H, Carlier S, Van Dyck D, De Backere F, Crombez G. Towards more personalized digital health interventions: a clustering method of action and coping plans to promote physical activity. BMC Public Health. 2022;22(1):2325. [CrossRef] [Medline]
- Chén OY, Roberts B. Personalized health care and public health in the digital age. Front Digit Health. 2021;3:595704. [CrossRef] [Medline]
- Martos-Cabrera MB, Velando-Soriano A, Pradas-Hernández L, et al. Smartphones and apps to control glycosylated hemoglobin (HbA1c) level in diabetes: a systematic review and meta-analysis. J Clin Med. Mar 4, 2020;9(3):693. [CrossRef] [Medline]
Abbreviations
| KHPI: Korea Health Promotion Institute |
| OR: odds ratio |
| RCT: randomized controlled trial |
Edited by Lorraine Buis; submitted 19.07.24; peer-reviewed by Andreas Eisingerich, Nakyung Jeon; final revised version received 14.12.24; accepted 23.01.25; published 25.02.25.
Copyright© Kyung-In Joung, Sook Hee An, Joon Seok Bang, Kwang Joon Kim. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 25.2.2025.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on https://mhealth.jmir.org/, as well as this copyright and license information must be included.